Blue Note Therapeutics Product BNT 103 Usability and User Engagement

You may be eligible if

• Patient can read, write, and speak in English
• Patient is between the ages of 35-55
• Diagnosed with Stage I-III breast cancer
• In active treatment or within 3 months of ending active treatment and under the care of a clinician at time of study
• Apple mobile phone or tablet user
• Willing to participate in study protocol